hello there be fast please ,i will not accept

Our resolution of this matter is crucial because the three-year period would bar G & B's claims regarding defendants' 1988 publications as well as the alleged 1988 distribution of preprints at a librarians' conference. (Claims based on Barschall's 1986 article, of course, are barred under either a three-year or six-year period, as G & B did not bring this action until 1993.)

In support of its argument that the six-year period for fraud actions should govern, G & B relies onPepsiCo,578 F.Supp. 196. InPepsiCo,Judge Ward, addressing the issue as one of first impression, concluded that New York's six-year fraud period was more appropriate than the one-year period for libel actions which defendants in that action urged. The "federal policy at issue" in the Lanham Act, the court noted, "is the protection of `persons engaged in ... commerce against unfair competition' and the prevention of `fraud and deception in such commerce.'"Id.at 199 (quoting Lanham Act 45, 15 U.S.C. 1127). Although Section 43(a)'s "primary target" is trademark infringement, the court reasoned, "that section

1529

*1529applies as well to those deceptive business practices which, like trademark infringement, attempt to induce consumers to purchase an advertiser's goods by falsely passing them off as the same as, or better than those of a competitor. Such claims can best be analogized to causes of action sounding in fraud."Id.

additional questions1101120

Question 1

What is the maintenance dose of phenytoin in seizures arising as a

complication of chronic renal failure?

Question 2

I know that the loading dose of phenytoin in status epilepticus is

20 mg/kg with an upper limit of 1000 mg but if the same situation arose

as a complication of chronic renal failure (on regular dialysis), should

this dose remain the same or be reduced? If reduced, what should the

dose be?

Question 3

1. What is the most effective antiepileptic for a patient with simple

partial motor status epilepticus who is not responding to a loading

dose of phenytoin?

2. How long does phenytoin, given in a loading dose, take to work?

Question 4

Is valproate effective if given rectally in status epilepticus and, if so, what

dose is recommended?

Question 5

In simple partial motor status epilepticus, if the patient does not respond

to diazepam and phenytoin, is it justifiable to proceed to anaesthetic

medication?

Question 6

What is the recommended upper limit dose of lamotrigine when

combined with both carbamazepine and valproate?

Question 7

Is a valproate-lamotrigine combination more effective than

carbamazepine on its own against partial seizures?

Question 8

Why is the incidence of parkinsonism less common in smokers?

Question 9

Is it recommended to start the treatment of parkinsonism with dopamine

agonists alone in elderly (over 60 years old) patients, and to delay using

L-dopa until the disease has progressed much further? Is there a rationale

for this protocol in younger patients?

Question 10

Does amantadine increase the endogenous release of dopamine, thus

aiding early treatment of parkinsonism